Want to join the conversation?
$ULTA raised its 3Q16 comparable sales, including e-commerce sales, growth outlook to 14-15% from prior estimate of 11-13%, and its EPS guidance to range of $1.35-1.38 from prior forecast of $1.25-1.30. For 2016, $ULTA lifted comparable sales growth outlook to 12-14% from 11-13%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?